Roy Wiesner

Roy Wiesner is a Partner at aMoon Fund where he invests in early-stage healthtech (digital health, diagnostics, tech-enabled services, and medical devices). He focuses on Seed and Series A rounds across Israel, the Middle East, and Asia. He serves on the boards of Magentiq Eye Ltd., Ibex Medical Analytics, Eleos Health, AtaCor Medical, Inc., and Igentify, and has invested in companies including Ibex Medical Analytics, Eleos Health, AtaCor Medical, Inc., Igentify, and Magentiq Eye Ltd. Previously, he was Managing Director at aMoon Fund and served as an Observer on the Investment Committee of RMGP Biopharma Investment Fund. Roy studied at Columbia | SIPA, The London School of Economics and Political Science (LSE), Harvard Business School, and The Hebrew University of Jerusalem, and lives in Israel.